Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol Reynolds

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Blood|May 6, 2017
Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host diseaseYi-Bin Chen, Miguel-Angel Perales, Shuli Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashesMatthew P Goetz, James M Rae, Vera J Suman, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2009
The Snf1-related kinase, Hunk, is essential for mammary tumor metastasisGerald B W Wertheim, Thomas W Yang, Tien-chi Pan, et al.
Breast Cancer Research and Treatment|June 8, 2010
Aromatase immunoreactivity is increased in mammographically dense regions of the breastCeline M Vachon, Hironobu Sasano, Karthik Ghosh, et al.
Blood Advances|January 4, 2018
Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCTVincent T Ho, Haesook T Kim, Natalie Bavli, et al.
Cancer|March 11, 2003
Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311Ted P Szatrowski, Richard K Dodge, Carol Reynolds, et al.
Blood|March 23, 2006
Rituximab for steroid-refractory chronic graft-versus-host diseaseCorey Cutler, David Miklos, Haesook T Kim, et al.
Trials|December 13, 2025
Behavioral Economic and Staffing Strategies To Increase Adoption of the ABCDEF Bundle in the Intensive Care Unit (BEST ICU): study protocol for a multi-site stepped-wedge cluster randomized controlled trial in the USAEduard E Vasilevskis, Jungyoon Kim, Christopher Wichman, et al.
Blood Advances|January 26, 2021
Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamideBenedetta Rambaldi, Haesook T Kim, Carol Reynolds, et al.
Blood Advances|September 4, 2020
Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemiaHaesook T Kim, Conner J Shaughnessy, Sharmila C Rai, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Blood|May 6, 2017
Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host diseaseYi-Bin Chen, Miguel-Angel Perales, Shuli Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashesMatthew P Goetz, James M Rae, Vera J Suman, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2009
The Snf1-related kinase, Hunk, is essential for mammary tumor metastasisGerald B W Wertheim, Thomas W Yang, Tien-chi Pan, et al.
Breast Cancer Research and Treatment|June 8, 2010
Aromatase immunoreactivity is increased in mammographically dense regions of the breastCeline M Vachon, Hironobu Sasano, Karthik Ghosh, et al.
Blood Advances|January 4, 2018
Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCTVincent T Ho, Haesook T Kim, Natalie Bavli, et al.
Cancer|March 11, 2003
Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311Ted P Szatrowski, Richard K Dodge, Carol Reynolds, et al.
Blood|March 23, 2006
Rituximab for steroid-refractory chronic graft-versus-host diseaseCorey Cutler, David Miklos, Haesook T Kim, et al.
Trials|December 13, 2025
Behavioral Economic and Staffing Strategies To Increase Adoption of the ABCDEF Bundle in the Intensive Care Unit (BEST ICU): study protocol for a multi-site stepped-wedge cluster randomized controlled trial in the USAEduard E Vasilevskis, Jungyoon Kim, Christopher Wichman, et al.
Blood Advances|January 26, 2021
Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamideBenedetta Rambaldi, Haesook T Kim, Carol Reynolds, et al.
Blood Advances|September 4, 2020
Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemiaHaesook T Kim, Conner J Shaughnessy, Sharmila C Rai, et al.
Pageof 10